Orphan designation: Recombinant human factor IX protein modified with three point mutations (dalcinonacog alfa), Treatment of haemophilia B, 20/06/2017, Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 3 August 2023 - 15:42

Orphan designation: Recombinant human factor IX protein modified with three point mutations (dalcinonacog alfa), Treatment of haemophilia B, 20/06/2017, Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-17-1884

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters